Massachusetts 2023-2024 Regular Session

Massachusetts House Bill H1183

Introduced
2/16/23  

Caption

Advancing health care research and decision-making centered on patients and people with disabilities

Impact

The bill mandates that the Division of Medical Assistance establishes standards for evaluating healthcare research and analysis. This includes assessing outcomes that matter most to patients, as well as taking into account differences among patient subgroups. This is a significant shift towards tailoring healthcare policies to meet the nuanced needs of diverse patient populations, which could lead to enhanced healthcare experiences and outcomes. By emphasizing scientific rigor and avoiding reliance on potentially discriminatory measures, the bill supports a more equitable approach to healthcare delivery.

Summary

House Bill H1183, titled 'An Act advancing health care research and decision-making centered on patients and people with disabilities,' aims to amend Chapter 118E of the General Laws. This bill introduces standards for patient-centeredness in healthcare research and decision-making, focusing particularly on the needs and preferences of patients and individuals with disabilities. The legislation seeks to ensure that any research utilized by state agencies in determining healthcare access is reflective of patient outcomes prioritized by these groups, promoting inclusivity and relevance in healthcare policy decisions.

Conclusion

The legislation not only aims to reshape healthcare policy in a way that centers patient experiences but also reinforces the significance of research quality and patient engagement. By calling for the evaluation of care through the lens of those most affected — patients and individuals with disabilities — H1183 sets the stage for a more responsive and just healthcare framework in the Commonwealth of Massachusetts.

Contention

Notable points of contention surrounding H1183 include the prohibition of using certain measures in making cost-effectiveness assessments, such as the dollars-per-quality adjusted life year metric. Critics may argue about the implications of such prohibitions on budgetary constraints and resource allocation. Additionally, the need for mechanisms like appeals and physician overrides suggests a potential for disputes over healthcare access, especially as the bill seeks to protect physician decision-making in contexts where patient access might otherwise be restricted.

Companion Bills

MA S109

Similar To Relative to supported decision-making agreements for certain adults with disabilities

MA H4634

Replaced by Study Order

Previously Filed As

MA H1358

Advancing health care research and decision-making centered on patients and people with disabilities

MA S730

Advancing health care research and decision-making centered on patients and people with disabilities

MA S465

Supporting individuals suffering with amyotrophic lateral sclerosis and their families

MA H1134

To improve access and care coordination for people with pain

MA H2399

To improve access to health care for people with Long COVID

MA A08648

Extends the provisions of the family health care decisions act in the public health law to health care decisions for patients with intellectual or developmental disabilities.

MA H2221

Improving health care for patients with intellectual and developmental disabilities including autism

MA H986

Relative to telehealth and digital equity for patients

MA H1130

Relative to telehealth and digital equity for patients

MA H5996

Healthcare Assistance For Working People With Disabilities

Similar Bills

CA AB922

Reproductive health and research: oocyte procurement.

HI SB2304

Relating To The Research Corporation Of The University Of Hawaii.

HI SB3208

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1204

Relating To The University Of Hawaii.

CA SB934

California Childhood Cancer Research Fund Act.

CA AB1103

Controlled substances: research.